Neal Scott Mason

1.1k total citations
4 papers, 38 citations indexed

About

Neal Scott Mason is a scholar working on Physiology, Molecular Biology and Pharmacology. According to data from OpenAlex, Neal Scott Mason has authored 4 papers receiving a total of 38 indexed citations (citations by other indexed papers that have themselves been cited), including 2 papers in Physiology, 1 paper in Molecular Biology and 1 paper in Pharmacology. Recurrent topics in Neal Scott Mason's work include Alzheimer's disease research and treatments (2 papers), Adenosine and Purinergic Signaling (1 paper) and Cholinesterase and Neurodegenerative Diseases (1 paper). Neal Scott Mason is often cited by papers focused on Alzheimer's disease research and treatments (2 papers), Adenosine and Purinergic Signaling (1 paper) and Cholinesterase and Neurodegenerative Diseases (1 paper). Neal Scott Mason collaborates with scholars based in United States and New Zealand. Neal Scott Mason's co-authors include William R. Wilson, Joel S. Greenberger, Anthony Kanai, Stephen Y. Lai, William E. Klunk, Scott K. Ziolko, Brian J. Lopresti, Chester A. Mathis, Steven T. DeKosky and Wenzhu Bi and has published in prestigious journals such as NeuroImage, Alzheimer s & Dementia and In Vivo.

In The Last Decade

Neal Scott Mason

4 papers receiving 37 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Neal Scott Mason United States 2 18 13 12 6 5 4 38
Jean‐Jacques Gérardy Luxembourg 5 13 0.7× 4 0.3× 10 0.8× 3 0.5× 24 4.8× 9 70
Zili Han China 3 10 0.6× 14 1.1× 2 0.2× 15 2.5× 28 5.6× 6 54
Marta Fragoso Spain 3 8 0.4× 12 0.9× 2 0.2× 2 0.4× 8 32
Allison Beller United States 2 5 0.3× 8 0.6× 4 0.3× 1 0.2× 4 0.8× 2 41
Vuk Šćepanović Serbia 5 8 0.4× 2 0.2× 6 0.5× 1 0.2× 6 1.2× 18 61
Charlotte C.G. Ho United States 3 19 1.1× 11 0.8× 1 0.1× 4 0.7× 10 2.0× 4 35
Filippos Anagnostakis United States 4 11 0.6× 5 0.4× 3 0.3× 1 0.2× 18 3.6× 8 46
Sterling C. Johnson United States 2 25 1.4× 5 0.4× 3 0.3× 3 0.5× 43 8.6× 11 57
Hsiao-Yi Lin Taiwan 3 4 0.2× 9 0.7× 2 0.2× 4 0.7× 8 1.6× 4 46
Corinne Perrin France 4 13 0.7× 2 0.2× 2 0.2× 8 1.3× 12 2.4× 4 58

Countries citing papers authored by Neal Scott Mason

Since Specialization
Citations

This map shows the geographic impact of Neal Scott Mason's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Neal Scott Mason with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Neal Scott Mason more than expected).

Fields of papers citing papers by Neal Scott Mason

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Neal Scott Mason. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Neal Scott Mason. The network helps show where Neal Scott Mason may publish in the future.

Co-authorship network of co-authors of Neal Scott Mason

This figure shows the co-authorship network connecting the top 25 collaborators of Neal Scott Mason. A scholar is included among the top collaborators of Neal Scott Mason based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Neal Scott Mason. Neal Scott Mason is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

4 of 4 papers shown
1.
Epperly, Michael W., Stephen Y. Lai, Anthony Kanai, et al.. (2010). Effectiveness of combined modality radiotherapy of orthotopic human squamous cell carcinomas in Nu/Nu mice using cetuximab, tirapazamine and MnSOD-plasmid liposome gene therapy.. In Vivo. 24(1). 1–8. 16 indexed citations
2.
Mathis, Chester A., Miloš D. Ikonomović, Neal Scott Mason, et al.. (2009). P2‐007: Pharmacologic and pharmacokinetic equivalence studies of GE‐067 to PiB. Alzheimer s & Dementia. 5(4S_Part_9). 1 indexed citations
3.
Mathis, Chester A., Brian J. Lopresti, Neal Scott Mason, et al.. (2007). Comparison of the amyloid imaging agents [F-18]3’-F-PIB and [C-11]PIB in Alzheimer's disease and control subjects. 48. 20 indexed citations
4.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jean‐Jacques Gérardy Breakdown of academic impact, for papers by Zili Han Breakdown of academic impact, for papers by Marta Fragoso Breakdown of academic impact, for papers by Allison Beller Breakdown of academic impact, for papers by Vuk Šćepanović Breakdown of academic impact, for papers by Charlotte C.G. Ho Breakdown of academic impact, for papers by Filippos Anagnostakis Breakdown of academic impact, for papers by Sterling C. Johnson Breakdown of academic impact, for papers by Hsiao-Yi Lin Breakdown of academic impact, for papers by Corinne Perrin
Rankless by CCL
2026